As patients evolve into healthcare consumers, expecting better and improved health, Life Sciences companies are becoming more patient-centric.[1]
The pandemic has increased trial activities conducted remotely and in participants’ homes, furthering the shift from centralized to decentralized clinical trials.[2]
The need for efficiency continues to drive the industry with half of new Life Sciences businesses expecting to move to cloud-based ecosystems by 2026.[3]
Product development timelines are accelerated by advances in personalized medicine and unmet needs, requiring improved knowledge transfer among healthcare collaborators.[4]
With growing amounts of intellectual property and public health data, ransomware attacks on Life Sciences companies are rising, with a 50% jump from 2019 to 2020 alone.[5]
To ensure supply chain flexibility and resilience and avoid demand disruptions, Life Sciences companies are looking to integration solutions with end-to-end visibility.[6]
Build a better-connected drug development value chain with smarter document management
Realize operational efficiencies with secure access, fast deployment and flexible upgrades
Create and manage critical quality and manufacturing documentation using GMP standards
Partner with a team that has more than 25 years of experience transforming and automating Life Sciences processes to improve asset management and information governance.
Leverage a solution portfolio that utilizes information assets from R&D to commercialization to address today’s trends and prepare for tomorrow’s challenges.
Learn how leading Life Sciences organizations lean on OpenText solutions.
See more success stories